Theseus Pharmaceuticals, Inc. (THRX)
Theseus Pharmaceuticals, Inc. engages in the development of pan-variant kinase inhibitors. It focuses on the discovery, development and commercialization of transformative targeted therapies. The company was founded by William C. Shakespeare, David C. Dalgarno, Iain D. Dukes, Wei Sheng Huang and Victor M. Rivera on December 29, 2017 and is headquartered in Cambridge, MA.
Address
314 MAIN STREET, SUITE 04-200
CAMBRIDGE, MA 02142
Founded
2017
Number of Employees
38
Website
http://www.theseusrx.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)